Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho-related GTP-binding protein RhoT2 (RHOT2/MIRO2) is a member of the RHO GTPase family, functioning as a mitochondrial outer membrane protein that regulates mitochondrial trafficking, distribution, and quality control within cells[2]. It acts as a molecular switch, cycling between active (GTP-bound) and inactive (GDP-bound) states, and participates in signal transduction pathways by interacting with a large network of regulatory proteins including guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and downstream effectors[2]. Aberrations in RHOT2/MIRO2 signaling are implicated in cancer progression (especially cell migration and invasion) and in neurodegenerative diseases due to its essential role in mitochondrial dynamics[1][2]. Therapeutic targeting of RHO GTPases, including RHOT2, remains challenging due to the complexity and ubiquity of their signaling roles in normal physiology[1].
Potential inhibition of mitochondrial trafficking; Modulation of RHO GTPase signaling in cell migration, invasion, and cytoskeletal dynamics
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho-related GTP-binding protein RhoT2 (RHOT2 (sometimes MIRO2)).